BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, December 21, 2025
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

In the clinic for Feb. 26, 2020

Feb. 26, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: CareDx, Cardiac Dimensions, Novavision, Rti Surgical.
Read More

Financings for Feb. 26, 2020

Feb. 26, 2020
Med-tech firms raising money in public or private financings, including: Nuvasive, Ribbon Health.
Read More

Appointments and advancements for Feb. 26, 2020

Feb. 26, 2020
New hires and promotions in the med-tech industry, including: Concord Technologies, Iradimed, Jvion, Pulmonx.
Read More

Regulatory actions for Feb. 26, 2020

Feb. 26, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alnylam, Kiadis, Puma, Translate Bio.
Read More

Other news to note for Feb. 26, 2020

Feb. 26, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arcus, Dialectic, Novavax, Promis, Pvp Biologics, Taiho, Takeda, Tonix.
Read More

In the clinic for Feb. 26, 2020

Feb. 26, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Actinium, Akcea, Amgen, Apeiron, Bayer, Cyclo, Cytokinetics, Exelixis, Fulcrum, GT Biopharma, Inflarx, Ionctura, Menlo, Oramed, Seelos, Sellas, Servier, Vanda, Zynerba.
Read More

Financings for Feb. 26, 2020

Feb. 26, 2020
Biopharmas raising money in public or private financings, including: Aptorum, Genmab, MPM Capital, Outlook.
Read More

Earnings for Feb. 26, 2020

Feb. 26, 2020
Quarterly snapshots from biopharma companies with marketed products, including: Amarin, Jazz, United Therapeutics, Vanda.
Read More

Appointments and advancements for Feb. 26, 2020

Feb. 26, 2020
New hires and promotions in the biopharma industry, including: Curevac, Nordic Nanovector, Nouscom, Summit.
Read More

Other news to note for Feb. 25, 2020

Feb. 25, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 1st Biotherapeutics, Arecor, Artizan, Astrazeneca, Atrin, Auris, Axovant, Certara, Daiichi Sankyo, Domainex, Dyadic, Excellerate, Immunos, In Silico, Index, Kahr, Lipocine, Lunac, Mallinckrodt, Moderna, Nektar, Omass, Oncologie, Peptilogics, Point Predictive Technology Group, Probiogen, Promis, Proteostasis, Redhill, Roche, Spring Bank, Tetra, Trianni, Twoxar, Vir, Wuxi.
Read More
Previous 1 2 … 1603 1604 1605 1606 1607 1608 1609 1610 1611 … 1720 1721 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 19, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 19, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing